This article is licensed under.

In most cases can be treated outpatient. Typically, antibiotics, rest, fluids, and home care enough to completely fix. However, people with pneumonia who have breathing problems, people with other medical problems, and older people may need more advanced treatment. If symptoms worsen, pneumonia does not improve with home treatment or complications, people often have to be hospitalized. Antibiotics used to treat bacterial pneumonia. In contrast, antibiotics are not useful for viral pneumonia, although they are sometimes used to treat and prevent bacterial infections that can occur in lungs damaged by virus. Antibiotic choice depends on the nature of pneumonia, the most common bacteria that cause pneumonia in the local geographical area, and immune status and basic health. Treatment of pneumonia should ideally be based on the causative organism and its sensitivity to antibiotics known. However, the specific causes of pneumonia identified in only 50% of people even after a thorough evaluation. Because treatment is usually not delayed in any person with serious empirical therapy usually begins well before laboratory reports are available. In the United Kingdom, amoxicillin and clarithromycin or erythromycin are the antibiotics selected for most patients with community acquired pneumonia, patients allergic to penicillins are given erythromycin instead of amoxicillin. In North America, where atypical forms of pneumonia are becoming more common, macrolides (eg, azithromycin and clarithromycin), fluoroquinolones, doxycycline and amoxicillin replaced as first-line outpatient treatment of pneumonia. Duration of treatment traditionally seven to ten days, but there is more evidence that short courses (as short three days) is sufficient. Antibiotics for nosocomial pneumonia include third and fourth generation cephalosporins, karbapenemy, fluoroquinolones, aminoglycosides and vancomycin strattera 25mg. These antibiotics are usually administered intravenously. Several antibiotics can be administered in combination in an attempt to consider all the possible causative microorganisms. Antibiotic selection varies from hospital to hospital because of regional differences in the most probable microorganisms, as well as differences in the ability of microorganisms to antibiotics resist various treatments. People who have difficulty breathing may need extra oxygen. Very sick people may require intensive therapy, often including intubation and mechanical ventilation. Viral pneumonia caused can be treated Remantadin or amantadine, while viral pneumonia caused by influenza A or B can be processed

or. These procedures are useful only if started within 48 hours after onset of symptoms. Many strains

flu, also known as avian influenza or have shown resistance to amantadine and Remantadin. There is no known effective treatment of viral pneumonia caused by SARS coronavirus, adenovirus, or parainfluenza. There is no evidence to support the use of antibiotics in chemical pneumonia without bacterial infection. If infection is present in aspiration pneumonia, the choice of antibiotic will depend on several factors, including the suspected causative agent of pneumonia is or was acquired in the community or developed in the hospital. Common options include clindamycin, a combination of beta-lactam antibiotics and metronidazole or aminoglycosides. Corticosteroids are widely used in the quest, but there is no evidence to support their use, too. Viral pneumonia may last longer, and mycoplasma pneumonia may take four to six weeks to completely resolve. In cases where the pneumonia progresses blood poisoning (bacteremia), slightly more than 20% of patients die. Mortality (or mortality) also depends on the root cause pneumonia. caused by Mycoplasma'''', for example, is associated with little mortality. However, about half of people who develop methicillin-resistant''

'' (MRSA) pneumonia while on the ventilator will die. In regions of the world without modern health care systems, pneumonia is even more deadly. Limited access to clinics and hospitals, limited access to X-rays, limited antibiotic choices, and the inability to treat the basic conditions inevitably leads to an increase in the number of deaths from pneumonia. For these reasons, the majority of deaths among children under five years due to pneumococcal infection occurs in developing coutries. - Online calculator

CURB-65 score, which takes into account the severity of the symptoms of existing disease, and age - online calculator

This article is licensed under. It uses material from the Wikipedia article on >> << All materials used are adapted from Wikipedia is available under the terms and conditions. Wikipedia ® itself is a registered trademark of the Wikimedia Foundation, Inc.

In 14 rats used as controls.

Harry G. Preys, Bobby Echard, Ryan Reza Zonosi

volatile aromatic oils and medium fatty acids derived from edible plants possess interesting antimicrobial properties - properties are generally not recognized by state or, in this regard, to the medical profession. Antimicrobial activity of oregano oil is due largely to a high content of phenolic components, such as karvakrol and thymol. Lauric acid, found primarily in coconut and palm oil, can form monolaurin in the body, monoglycerides with high antimicrobial potential. We recently compared the efficacy of antimicrobial oregano oil and other essential oils and monolaurin in vitro by studying fungi (C Albicans) and a variety of bacteria by the method mikrorozveden. Oregano oil, the most powerful of the essential oils tested and proven monolaurin cidal in a culture different bacteria. However, only oregano, not monolaurin is cidal to C. Albicans. In vivo experiments in mice have shown oregano oil and monolaurin, individually and in combination to be as effective as some antibiotics. Oregano oil and / or monolaurin may prove useful antimicrobial drugs to prevent and treat a variety of infectious organisms in different circumstances. The total worldwide health problems caused by heavy, difficult to treat infectious diseases has become over time. While the standard approach is to use drugs, medications was not a complete solution. Too many deadly microbes created a resistance to many antibiotics still strong, despite further development over time is more complicated antimicrobial agents. More disturbing is that many antimicrobial drugs were also associated with severe adverse reactions. Thus, safe and effective antimicrobial drugs for treatment of a wide range of both therapeutic and prophylactic broad spectrum of infections is needed. This is especially true for many treatment-resistant antimicrobial organisms as staphylococci (1-9) and tuberculosis. (10) Problem staph infection is persistent, insidious threat to hospitalized patients. Tuberculosis remains one of the technical and clinical problems of drug-resistant forms are becoming more common worldwide. (10.11) can use many difficult to treat, life-threatening microorganisms as weapons of terrorism is a necessary need for safe antimicrobial agents. As an example of the latter, spores of anthrax bacilli have recently been used as a large number of victims of weapons. (12-15)

To state the obvious, the best therapeutic antimicrobial drugs are virtually no side effects, have a wide range of activities, and probably will not encounter resistance to their therapeutic effect over time. The number of natural products, including several essential oils and some fats (monoglycerides) seems to have some of these ideal characteristics. Essential oils are used for food preservation since the early explorers. (16) Thus, it is not very surprising that they were found to be effective for many pathogenic organisms. (16-22) Some of monoglycerides and fatty acids, also found that the antimicrobial potential. (23) lauric acid is the main antiviral and antibacterial substance in human breast milk. Coconut products and palm oil are the main sources of this medium chain saturated fatty acids. Monolaurin, glycerin, ether laurynovoy acids, more biologically active than laurynovoy acid. Optimal antimicrobial activity for fatty acids and their corresponding monoglycerides are chain length C12. (24). Lauric acid (C12) has a higher antiviral activity than caprylic acid (C8), kaprinovaya acid (C10) or myristic acid (C14). (24)

We conducted a series of in vitro and in vivo studies to determine the potential of essential oils and fat monolaurin alone or in combination for treatment of various organisms. (25-27) with 12 essential oils tested, oregano consistently fairer treatment for the organism studied. (26.27) We also confirmed that the fat monolaurin is cidal in a variety of organisms. (26.27)

We used a micro-broth dilution technique to determine the sensitivity of Candida Albicans and various bacterial strains of oregano oil and other essential oils and monolaurin. (25-27) susceptibility was expressed as the minimum inhibitory and / or minimal cidal concentration. The minimum inhibitory concentration was defined as the lowest concentration of agent required to arrest the growth of fungi or bacteria, after 24 hours incubation. Minimum cidal concentration determined by seeding 0. 01 ml aliquots of culture medium taken from the tube after 48 hours on agar and incubated for further growth. Plates were scored for growth of colonies of bacteria. The lowest concentration of antibacterial agent causing negative growth (fewer than three colonies) was considered the minimum cidal concentration. Using the above methodology, we examined in vitro cidal and / or static effects of oregano oil, a few other essential oils and monolaurin for Candida Albicans, Staphylococcus aureus, bacillus anthrax Stern (model B. anthrax), Escherichia coli, Klebsiella pneumonia, helicobacter, and Mycobacterium Terrae (model for Mycobacterium tuberculosis). As oil oregano consistently proved the most effective essential oil, we will limit our discussion of the essential oil. Oil of oregano has been effective enough in reasonable concentrations relative to C. Albicans. (25) was found to completely inhibit the growth of C. Albicans in culture for 250 ug / ml. In contrast, monolaurin in our hands was not effective against the fungus. In the study of bacteria, oregano oil has proved cidal to all tested organisms mentioned above, except for B. anthrax Stern, for which it was static. (27) monolaurin was cidal to Staphylococcus aureus and M. Terrae but not E. coli and K. pneumonia. It was noted that well-monolaurin is mainly against gram-positive bacteria rather than Gram-negative. However, H.pylori were extremely sensitive to monolaurin contrast to two other gram-negative microorganisms. As oil of oregano, monolaurin was static, not cidal B. Stern anthrax. ? "Prepared to" How can we put these results in perspective, because many of us were inclined vitro treatments that never Consequently, the first question we must answer the following: whether it is a natural substance effectively in vivo? In first approximation, we investigated the therapeutic effectiveness of oregano oil in the experimental murine model of systemic candidiasis. (25) Groups of six mice infected with C. Albicans (5 X [LD. Sat. 50]) and fed different amount of oil oregano in a finite volume 0. 1 ml of olive oil (vehicle). Daily administration 8. 6 mg in 100 ml of oregano olive oil / kg body weight for 30 days resulted in 80% survival without renal burden of C. Albicans in comparison with a group of mice that received only olive oil. The latter died within 10 days. Next, 14 mice were infected with Staphylococcus aureus and injected daily with oil, oregano, monolaurin, or combined oregano and monolaurin within 30 days. (26) of bacterial agents administered was calculated based on body weight of mice. Control mice received daily gavages or an olive oil (negative control) or olive oil orally plus vancomycin (400 mg), F (positive control). Daily dose of oregano was 3 years. 2 mg. Monolaurin was given in the same dose, and when both drugs were combined, the same individual doses were used, i. e, 3. 2 mg each. Experiments were terminated at the end of 30 days. We found that oregano oil and monolaurin is protective, at least to some extent in vivo. (26) In 14 rats used as controls. Staphylococcus aureus (ATSS # 14775) killed all order strattera mice within 7 days. On the other hand, 37. 5% -50% of mice survived for 30 days after receiving daily gavages vancomycin (7/14), oregano oil (6/14) and monolaurin (4/8). Survival when combined oregano oil and monolaurin was a little better - 62. 5% (5/8). It is clear that further research to establish whether the combination of superior natural products for personal use, especially if higher doses of individual agents are used. Interestingly, no abscesses were found in postmortem and Staphylococcus aureus can be grown with kidney 30-day survivors offering treatment. .

Bђњthe difference on the seventh day was 0.

Antibiotics that doctors usually prescribed for sinus not reduce symptoms better than inactive placebo, according to investigators, the Washington University School of Medicine in St. Louis. BЂњPatients donBЂ ™ t better faster and have fewer symptoms when they get antibiotics BЂ "said Jay F. Piccirillo, MD, professor of otolaryngology and studyBЂ ™ s main author. BЂњOur results show that antibiotics arenBЂ ™ t need for primary sinusitis BЂ "most people better themselves. BЂ "

The results were published February 15

Journal of the American Medical Association. In the United States more than one in five antibiotics are designed to slot

indicate the authors. And given the growth of bacteria resistant to these drugs, they say that it is important to determine whether this treatment is effective. Their results show that it is not. Antibiotics BЂњWe feeling is abuse in primary care settings BЂ "says Jane M. Garbutt, MD, research assistant professor of medicine and first author paperBЂ ™ s. BЂњThere the movement in motion, led by the Centre for Disease Control and Prevention to try to improve the rational use of antibiotics. We hope that this study provides scientific evidence that doctors can use with patients to explain that antibiotics can not help acute sinusitis. BЂ "

In practice, instead of antibiotics such as amoxicillin are used in this study, researchers propose to treat symptoms such as pain, cough and congestion and waiting tactics or further treatment. The study included 166 adults, whose symptoms meet the criteria for acute sinusitis recommended by the panel convened by the Centers for Disease Control and Prevention. To participate, patientsBЂ ™ symptoms were to be classified as moderate, severe or very severe. In particular, they had to report pain or tenderness in the face and nose and nasal discharge, which lasted from seven to 28 days. Patients with chronic sinus infections or serious complications from conditions such as ear infection or simultaneous breast that were not included in the study. Patients were recruited in their primary health physiciansBЂ ™ offices in St. Louis and were randomized to receive 10-day course or amoxicillin or placebo. Not to amoxicillin or not, all patients received medication for pain, fever, congestion and cough. Researchers rated patientsBЂ ™ symptoms in the early treatment, then three, seven, 10 and 28 days thereafter. At each point in time, patients answered questionnaires assessing the quality of life measurement associated with the disease, called sinuses of test results 16 (snot-16). They also compared the recurrence of symptoms and days missed from work. On the third day, they found no difference between antibiotic and placebo in any of these events. On the seventh day, a slight improvement was seen in antibiotic groupBЂ ™ s assessment questionnaire. However, Garbutt says that this small change is hardly noticeable relief of symptoms. BЂњOn scale of 1 to 3, we estimate that clinically significant difference would change 0. 5 snot-16 scores BЂ «Garbutt said. BЂњThe difference on the seventh day was 0. 19. Although this was statistically significant changes itBЂ ™ will likely not change that the patient will not notice. BЂ "

In addition, this modest improvement of statistical gone ten days, when about 80 percent of patients in both groups reported that their symptoms were greatly improved or cured. They also found no difference between antibiotic and placebo in the amount of medication patients decided to use to relieve pain, fever, congestion and cough. BЂњItBЂ ™ SA nasty disease BЂ «Garbutt said. BЂњPeople significant symptoms. They feel unhappy and miss from work time. If the antibiotic is not purchase strattera any good, then what? ThatBЂ ™ SA issue that we havenBЂ ™ t answer. But we are working on it. BЂ. "

Availability &gt;&gt; &lt;&lt; wound drainage...

Airborne diseases caused by pathogenic microbes small enough to be released

from an infected person through coughing, sneezing, laughing and close personal contacts or aerozolizatsii

microbe. The patient was discharged >> << microbes remain suspended in air, dust, respiratory and water drops. The disease occurs when a microbe inhale or contact of mucous secretions or when left

on the surface affected. Transfer air diseases can be significantly reduced by practicing

Social and respiratory etiquette. Staying at home in case of illness, keeping close contact with sick person to

minimum, allowing a little distance from the other foot during his illness, and in the mask, covering coughs and sneezes

elbow or tissue can significantly reduce transmission. Good hand washing can reduce the spread of sex

contain droplets that can be raised by hand from the surface or hand contact with secretions. Environmental >> << management and engineering alternatives to reduce the transmission of airborne pathogens drops of water. Contact disease transmitted when the infected person has direct physical contact

with an infected person, and the microbe is passed from one to another. Contact disease can be transmitted through

indirect contact with infected people or environment of personal belongings. Availability >> << wound drainage or other discharge from the body suggest an increased potential for risk transfer

and pollution. Safety measures that create barriers and procedures that reduce or eliminate >> << microbes in the environment or personal items that form the basis of interrupting disease transmission

direct contact. - A serious disease caused by Bacillus anthrax, the bacteria that form spores. Bacteria are very small body, consisting of a single cell. Many bacteria can cause disease. >> << The dispute is the center, which is at rest (sleep), but can come to life terms. - Bacteria commonly found in the throat and on

skin. People may carry group A streptococci in the throat or the skin and have no symptoms >> << disease. Most infections of gas in relatively mild illness such as strep throat or impetigo

. Sometimes these bacteria can cause serious and even life-threatening disease. - The bacterium that causes disease >> << in newborns, pregnant women, the elderly and adults with other diseases such as diabetes

or liver disease. GBS is strattera without prescritpion the most common cause of life-threatening infections in newborns. - Invasive disease caused by Haemophilus influenzae may affect

many organs and systems. The most common types of invasive disease is pneumonia, feverish occult bacteremia, meningitis

, epihlotyt, septic arthritis, cellulitis, otitis media, purulent pericarditis, and

other less common infections such as endocarditis and osteomyelitis. - Infection caused by the bacterium Legionella

Pneumophila. Man controls the frequency of legionellosis through mandatory reporting by health care

, clinical laboratories and other social partners in health. - The leading cause of bacterial meningitis in children and young adults >> << in the United States. Symptoms of meningococcal disease include fever, headache and stiff neck >> << B meningitis and sepsis and rash in meninhokokkemiya. - Metytsyllyn-resistant staphylococcus gold is a bacterial infection that is resistant to some antibiotics

. When MRSA bacteria are on the skin, but do not cause disease is called colonization. In most cases

MRSA does not cause any problems or causes minor infections such as pimples or boils. In some cases, MRSA can cause more serious infections. - Gram-positive cocci that encapsulated

frequently colonizing human nasopharynx, where it can be carried asymptomatically. - Respiratory diseases caused by coronavirus, the last in 2004 >> <<